Unique Testing Protocol From Precision Diagnostics Company Unlocks One Million Tests Per Day: The BillionToOne COVID-19 test uses different sets of instruments and chemicals from existing COVID-19 tests, enabling labs to unlock a new set of unused capacity.
BillionToOne has developed a highly accurate and cost-effective novel COVID-19 test protocol, unlocking more than one million testing capacity per day in the United States alone. Test reagents will be available in two weeks, pending manufacturing of kits and EUA from the FDA.
Test reagents will be available in two weeks, pending manufacturing of kits and EUA from the FDA. International laboratories without EUA requirements can start testing immediately by using their own reagents and the BillionToOne’s bioinformatics pipeline.
https://finance.yahoo.com/news/billiontoone-announces-groundbreaking-covid-19-140000160.html